Amacna, Leah Mae A.

HRN: 12-25-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/30/2026
08/06/2026
IV
500MG
Q8H
TETANUS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: